Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novartis Changing Of The Guard Continues As R&D Chief Bradner Exits
Merck & Co’s Marshall To Take Over
Sep 01 2022
•
By
Andrew McConaghie
Bradner has headed up the Cambridge, MA-headquartered NIBR since 2016, but will hand over to Fiona Marshall in November. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Immunological
More from Therapeutic Category